Multiple sclerosis drug slows brain shrinkage, study finds
Wednesday, August 29, 2018 - 18:30
in Health & Medicine
Results from a clinical trial of more than 250 participants with progressive multiple sclerosis (MS) revealed that ibudilast was better than a placebo in slowing down brain shrinkage. The study also showed that the main side effects of ibudilast were gastrointestinal and headaches.